Outlet track record
Eli Lilly and Company
U.S. large-cap pharmaceutical corporation
Eli Lilly and Company is a publicly traded U.S. pharmaceutical manufacturer headquartered in Indianapolis, Indiana, with no single controlling shareholder beyond a roughly 10% stake held by the Lilly Endowment, a private philanthropic foundation. The company is primarily funded by drug sales, and its business has surged in recent years on the back of its blockbuster GLP-1 weight-loss and diabetes drugs. Its relationship with the Trump administration has been cooperative in some areas — agreeing to lower obesity drug prices and committing tens of billions to domestic manufacturing — while clashing with the White House over proposed legislation to codify 'most favored nation' drug pricing into law.
Owned byPublicly traded (NYSE: LLY); Lilly Endowment, Inc. holds approximately 9.6% of common shares as of mid-2026; the remainder is broadly held by institutional investors including Vanguard, BlackRock, and State Street
LeaningU.S. large-cap pharmaceutical corporation
On the administrationmixed
5average bias score across 1 story
1 = straight reporting · 10 = heavily spun
1 = straight reporting · 10 = heavily spun